![](/img/cover-not-exists.png)
Dose escalation to rash for erlotinib plus gemcitabine for metastatic pancreatic cancer: the phase II RACHEL study
Van Cutsem, E, Li, C-P, Nowara, E, Aprile, G, Moore, M, Federowicz, I, Van Laethem, J-L, Hsu, C, Tham, C K, Stemmer, S M, Lipp, R, Zeaiter, A, Fittipaldo, A, Csutor, Z, Klughammer, B, Meng, X, CiuleanVolume:
111
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2014.494
Date:
November, 2014
File:
PDF, 562 KB
english, 2014